Skip to main content
. 2021 Sep 20;12:755625. doi: 10.3389/fphar.2021.755625

TABLE 2.

Univariate analysis for MELD score.

Statistics β (95%CI) p-value
Sex
 Female 118 (25.82%) Ref
 Male 339 (74.18%) −0.57 (−1.58, 0.43) 0.2627
Age 65.5 ± 12.9 −0.0 (−0.0, 0.0) 0.786
Smoking 149 (32.6%) 0.5 (−0.5, 1.4) 0.315
Drinking 132 (28.9%) 0.5 (−0.5, 1.4) 0.354
Diabetes 77 (16.8%) −0.7 (−1.8, 0.5) 0.271
Hypertension 76 (16.6%) −0.8 (−2.0, 0.4) 0.179
Hemoglobin, g/L
 >90 311 (68.1%) Ref
 60–90 125 (27.4%) 0.6 (−0.4, 1.6) 0.248
 <60 21 (4.6%) 1.9 (−0.2, 4.0) 0.074
Blood glucose 6.1 ± 3.0 −0.0 (−0.2, 0.1) 0.827
SBP 128.6 ± 19.1 −0.0 (−0.0, 0.0) 0.520
DBP 77.6 ± 11.8 0.0 (−0.0, 0.0) 0.988
MCV, fl 91.20 ± 9.86 0.04 (0.00, 0.09) 0.0485
Anemia classification
 Normocytic anemia 330 (72.21%) Ref
 Macrocytic anemia 72 (15.75%) 2.20 (0.99, 3.41) 0.0004
 Microcytic anemia 55 (12.04%) 0.34 (−1.01, 1.70) 0.6195

Abbreviations: MELD, model for end stage liver disease; β estimated coefficient; 95% CI 95% confidence interval; SBP, systolic blood pressure; DBP, diastolic blood pressure; MCV, mean corpuscular volume; fl.